A Pilot Study on Probing of Imatinib Induced Platelet Dysfunction in Patients with Chronic Myeloid Leukemia-Chronic Phase and Absence of Associated Bleeding Manifestation: Trying to Solve an Enigma-Reference-Cited by-同舟云学术

A Pilot Study on Probing of Imatinib Induced Platelet Dysfunction in Patients with Chronic Myeloid Leukemia-Chronic Phase and Absence of Associated Bleeding Manifestation: Trying to Solve an Enigma

Published:2020-11-13 Issue:1 Volume:37 Page:162-166
ISSN:0971-4502
Container-title:Indian Journal of Hematology and Blood Transfusion
language:en
Short-container-title:Indian J Hematol Blood Transfus

Author:

De Rajib,Chowdhury Ranjini,Dolai Tuphan Kanti,Bhar Biswajit,Islam Mohammad Mirazul,Chakrabarty Prantar,Deb Suryyani^ORCID

Funder

Science and Engineering Research Board

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12288-020-01376-8.pdf

Reference17 articles.

1. Peggs K, Mackinnon S (2003) Imatinibmesylate-the new gold standard for treatment of chronic myeloid leukemia. N Engl J Med 348:1048–1050

2. Deininger MW, O’Brien SG, Ford JM et al (2003) Practical management of patients with chronic myeloid leukemia receiving imatinib. J ClinOncol 21:1637–1647

3. Hochhaus A, Larson RA, Guilhot F et al (2017) Long-term outcomes of imatinib treatment for chronic myeloid leukemia. N Engl J Med 376:917–927

4. Quintás-Cardama A, Han X, Kantarjian H et al (2009) Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia. Blood 114:261–263

5. Jabbour E, Deininger M, Hochhaus A (2010) Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. Leukemia 25:201–210

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bleeding Diathesis as the Initial Presentation of Chronic Myeloid Leukemia: A Case Series;Cureus;2023-04-06